Hair Million promotes hair growth in both women and men. It is made of healthy and safe herbs that have been well documented and in use for thousands of years, especially in Asia. Although these herbs have not yet been scientifically proven by placebo-controlled clinical trials nor the ingedients of the herbs charaterized in laboratory, the herbal formula has been proven efficacious anecdotally in a number of people who experience hair thinning and hair loss. There are other herbs and nutritions that also work in anecdotal cases. For instance, Saw palmetto fruit extract have beens shown effective. Other herbs, such as sage, evening primrose, horse chestnut, horsetail, rosemary have been suggested. B vitamins, especially biotin might help as well.

Hair Million is a finest product that would ward off hair loss and promote hair growth, without side effect. Hair Million should be orally taken as suggested for a few months to see the positive effects: stopping hair thinning, and hair loss, and observing new hair growth. For some individuals, none of the hair growth products or methods would work, and the reasons are not always clear. People with alopecia areata would certainly benefit from Hair Million. Once you know it works for you, you could take it for months and years. It often results in complete restoration of hair.



  • Ultrastructural study of acquired pili torti-like hair defects accompanying pseudopelade.
  • Androgens and alopecia.
  • Hair loss during treatment with oral contraceptives
  • Hair pain (trichodynia): frequency and relationship to hair loss and patient gender.
  • Curly bare (cub), a new mouse mutation on chromosome 11 causing skin and hair abnormalities, and a modifier gene (mcub) on chromosome 5.
  • Notch/RBP-J Signaling Regulates Epidermis/Hair Fate Determination of Hair Follicular Stem Cells.
  • Assessment of hair loss: clinical relevance of hair growth evaluation methods.
  • Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
  • Effect of minoxidil on hair growth in androgenic alopecia in women
  • Primary follicular mucinosis: long-term follow-up of patients younger than 40 years with and without clonal T-cell receptor gene rearrangement.
  • A philosophy and strategy for surgical hair restoration: a 10-year experience.
  • Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy.
  • 'Cyclic alopecia' in Msx2 mutants: defects in hair cycling and hair shaft differentiation.
  • Alopecia areata in children: a clinical profile.
  • Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
  • Female pattern hair loss.
  • The potential role of minoxidil in the hair transplantation setting.
  • The potential role of minoxidil in the hair transplantation setting.
  • Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
  • Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
  • Weekly administration of paclitaxel and pirarubicine for recurrent breast cancer
  • Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
  • Nutritional factors and hair loss.
  • Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy.
  • A random study of Asian male androgenetic alopecia in Bangkok, Thailand.
  • Postmenopausal frontal fibrosing alopecia.
  • TrichoScan. A new instrument for digital hair analysis
  • Comparative efficacy of various treatment regimens for androgenetic alopecia in men.
  • The pattern and profile of alopecia areata in Singapore - a study of 219 Asians.
  • A philosophy and strategy for surgical hair restoration: a 10-year experience.
  • Inducible, reversible hair loss in transgenic mice.
  • Sensitization to saw palmetto and minoxidil in separate topical extemporaneous treatments for androgenetic alopecia.
  • Female pattern hair loss.
  • Loss of cell adhesion in Dsg3bal-Pas mice with homozygous deletion mutation (2079del14) in the desmoglein 3 gene.
  • Weekly administration of paclitaxel and pirarubicine for recurrent breast cancer
  • The pattern and profile of alopecia areata in Singapore - a study of 219 Asians.
  • Treatment of alopecia areata with diphencyprone
  • The art of repair in surgical hair restoration--part II: the tactics of repair.
  • Hormone-induced aberrations in electromagnetic adhesion signaling as a developmental factor of androgenetic alopecia.
  • A philosophy and strategy for surgical hair restoration: a 10-year experience.
  • Androgens and alopecia.
  • Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
  • Curly bare (cub), a new mouse mutation on chromosome 11 causing skin and hair abnormalities, and a modifier gene (mcub) on chromosome 5.
  • Approach to the adult female patient with diffuse nonscarring alopecia.
  • Disappearance of pili annulati following an episode of alopecia areata.
  • Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy.
  • Striae distensae - like lesions. A cause of scarring alopecia among children.
  • Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy.
  • Alopecia areata: update on therapy
  • Cosmetics and hair loss.
  • Dense-packing hair grafting technique for restoration of cicatricial alopecia
  • Alopecia universalis in a case of systemic lupus erythematosus.
  • Mouse models for human hair loss disorders.
  • Notch/RBP-J Signaling Regulates Epidermis/Hair Fate Determination of Hair Follicular Stem Cells.
  • Kenogen. A new phase of the hair cycle?
  • Androgenetic alopecia
  • Approach to the adult female patient with diffuse nonscarring alopecia.
  • There is no clear association between low serum ferritin and chronic diffuse telogen hair loss.
  • TrichoScan. A new instrument for digital hair analysis
  • Acute Diffuse and Total Alopecia of the Female Scalp. a new subtype of diffuse alopecia areata that has a favorable prognosis.
  • Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans.
  • Steroidogenic isoenzymes in human hair and their potential role in androgenetic alopecia.
  • Does the recipient site influence the hair growth characteristics in hair transplantation?
  • Postmenopausal frontal fibrosing alopecia. Report of 3 cases
  • Clinical relevance of hair microscopy in alopecia.
  • Langerhans cells that express matrix metalloproteinase 9 increase in human dermis during sensitization to diphenylcyclopropenone in patients with alopecia areata.
  • Hair loss in women with hyperandrogenism: four cases responding to finasteride.
  • Hair Transplantation for Men with Advanced Degrees of Hair Loss
  • Female pattern hair loss.
  • High-dose steroid pulse therapy for the treatment of severe alopecia areata.
  • Endocrinological disorders in association with alopecia areata-a 27 patients study
  • Hormonal interaction and hair growth
  • Loose anagen syndrome as a severity factor for trichotillomania.
  • A random study of Asian male androgenetic alopecia in Bangkok, Thailand.
  • 'Cyclic alopecia' in Msx2 mutants: defects in hair cycling and hair shaft differentiation.
  • Curly bare (cub), a new mouse mutation on chromosome 11 causing skin and hair abnormalities, and a modifier gene (mcub) on chromosome 5.
  • Androgens and alopecia.
  • Postmenopausal frontal fibrosing alopecia.
  • Dense-packing hair grafting technique for restoration of cicatricial alopecia
  • A philosophy and strategy for surgical hair restoration: a 10-year experience.



    Hair loss and hair growth online references:

    1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 |